Inclusion Criteria:
  -  Aged â‰¥18 years
  -  Attendance at study site
  -  Willing and able to provide written informed consent
Exclusion Criteria:
  -  Confirmed HCV RNA positive result (chronic HCV infection) prior to study recruitment
  -  Treatment experienced (either DAA or pegylated interferon)
  -  Hepatitis B virus (HBV) infected
  -  Human Immunodeficiency Virus (HIV) infected
  -  estimated glomerular filtration rate (eGFR) <30
  -  Active tuberculosis (if known active tuberculosis or as per symptom screening assessment)
  -  Pregnant women
  -  Serious drug-drug interaction with sofosbuvir/daclatasvir of a drug that the patient is unwilling or unable to stop taking